What's Going On With Gorilla Technology Stock Monday?
The Details: Citron called for the
The short-selling firm initially referenced a recent press release from the company, which highlighted a deal worth hundreds of billions with
Citron noted that if the individual in question is a different
The firm also questioned Gorilla Technlogy CEO’s claims that its upcoming token valuation will reach trillions. Additionally, it questioned how analysts can endorse a company that declares itself a global leader in AI-driven solutions while its Research and Development spending is minimal.
Benzinga has reached out to Gorilla for comment on the matter.
Related Link: Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable
GRRR Price Action: At the time of writing, Gorilla shares are trading 9.3% lower at
Image: This illustration was generated using artificial intelligence via Midjourney.
close
What's Going On With Gorilla Technology Stock Monday?
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "
Your e-mail has been sent.
close
Your e-mail has been sent.
Related News
-
Walgreens Boots' Stefano Pessina to almost double stake after Sycamore takeover, FT reports
Reuters - 20 minutes ago
-
NASA astronauts head home on SpaceX capsule after drawn-out space station stay
Reuters - 28 minutes ago
-
Walgreens Boots' Stefano Pessina to almost double stake after Sycamore takeover, FT reports
Reuters - 31 minutes ago
-
Sport-Women's elite sports to generate more than $2.35 billion in 2025, says Deloitte
Reuters - 32 minutes ago
-
Equinix issues its first Singaporean green bonds, raising $375 million
Reuters - 12:21 AM ET 3/18/2025
-
Factbox-Hedge funds, pharma CEOs on list of attendees for China business summit
Reuters - 12:06 AM ET 3/18/2025
-
China begins review of CK Hutchisons' port deal for security concerns, Bloomberg News reports
Reuters - 12:05 AM ET 3/18/2025
Content for this page, unless otherwise indicated with a Fidelity pyramid logo, is selected and published by Fidelity Interactive Content Services LLC ("FICS"), a Fidelity company. All Web pages published by FICS will contain this legend. FICS was established to present users with objective news, information, data and guidance on personal finance topics drawn from a diverse collection of sources including affiliated and non-affiliated financial services publications. Content selected and published by FICS drawn from affiliated Fidelity companies is labeled as such. FICS-selected content provided is not intended to provide tax, legal, insurance, or investment advice, and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by any Fidelity entity or any third party. Quotes are delayed unless otherwise noted. FICS is owned by FMR LLC and is an affiliate of Fidelity Brokerage Services LLC. Terms of use for Third-Party Content and Research
These links are provided by Fidelity Brokerage Services LLC ("FBS") for educational and informational purposes only. FBS is responsible for the information contained in the links. FICS and FBS are separate but affiliated companies and FICS is not involved in the preparation or selection of these links, nor does it explicitly or implicitly endorse or approve information contained in the links.
Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.
